GSK-3 is a highly conserved regulatory enzyme, and inhibition of GSK-3 activity by AKT-dependent phosphorylation was implicated in cancer progression, neuronal disease, aging, and metabolic disorders such as diabetes [66]. This evidence concerns the gene AKT1 and cancer.